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ABSTRACT 
Objectives: To assess the prevalence of viral hepatitis infec- 
tions in a sample of Kosovar refugees having arrived in south- 
ern Italy as a result of the 1999 war in the Balkans. 
Methods: The 526 subjects who enrolled on voluntary basis 
from all age groups were tested for the prevalence of serologic 
markers for hepatitis virus types A, B, C, D, and E (HAV, HBV, 
HCV, HDV, HEV). 
Results: Among the 526 refugees, the prevalence of total anti- 
HAV antibodies was 81%. A relevant finding was the presence 
of total anti-HAV antibodies in 61% of the children up to 10 
years of age. The prevalence of anti-HEV antibodies was 25% 
among the subjects. Fifteen subjects (2.9%) were positive for 
hepatitis B surface antigen (HBsAg), whereas 17.5% tested 
positive for anti-hepatitis B core antigen (anti-HBc). In children 
up to IO years of age, the prevalence of HBsAg and anti-HBc 
was found to be 0.4% and 6%, respectively. In subjects aged 
11 to 20 years, 4.2% tested positive for HBsAg and 20.2% for 
anti-HBc. In the age group 21 to 30 years, 7.1% of the sub- 
jects were found to be HBsAg carriers, whereas 25.9% were 
found to be positive for anti-HBc. Among the refugees over 
30 years of age, the prevalence of HBsAg was 4.2%, whereas 
anti-HBc was 43.7%. None of the refugees tested positive for 
anti-HDV. The prevalence of anti-HCV antibodies was 0.7%. 
Conc/usions: The results of this seroepidemiologic study indi- 
cate a high circulation of HAV in the Kosovar population, 
whereas the prevalence of HEV antibodies was low and com- 
parable to that of other European countries. The HBV infection 
seems to be at an intermediate level of endemicity and an 
immunization policy against HBV infection, through vaccina- 
tion of all newborns and children before adolescence, may be 
advisable. Results of this study indicate that the level of 
endemicity of HCV infection in the Kosovar population is low. 
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Since the early 1990s Puglia (southern Italy) has played 
the important role of frontier region in the Mediterranean 
area because of its vicinity to the Balkans. 
In March and April 1999, as a result of the armed 
conflict in the Kosovo province of the Federal Repub- 
lic ofYugoslavia, about 500,000 to 850,000 ethnic Alba- 
nians from Kosovo were forced to leave their homes 
and their land to seek refuge in neighboring countries, 
mainly Albania, Macedonia, and Montenegro.‘,’ As a 
result of these massive movements, many Kosovar peo- 
ple reached the coast of Puglia principally via Mon- 
tenegro and Albania. Upon arrival, the refugees, mainly 
children, were housed in refugee camps. This had also 
been the practice in 1991 and 1997, when Puglia expe- 
rienced an influx of Albanian refugees. The experience 
achieved in the field of public health during the two 
previous emergencies had permitted the planning of 
adequate preventive measures for this more recent exo- 
dus of Kosovar refugees. In 1991 and 1997, the purposes 
of survey studies carried out among the Albanian 
refugees were the surveillance of infectious diseases 
and the evaluation of the immunization coverage against 
vaccine-preventable diseases.‘-’ 
Viral hepatitis still represents a major health prob- 
lem in some areas of Europe, principally Eastern Europe.‘” 
Previous seroepidemiologic studies on immigrants from 
Albania revealed a high prevalence of hepatitis A virus 
(HAV) and hepatitis B virus (HBV) infections.11-‘3 In fact, 
more than 80% of the subjects tested positive for HAV 
antibodies, and about 13% of the refugees were infected 
chronically with HBV The findings of the latter studies 
suggested the urgent need for a vaccination policy against 
hepatitis B in the Albanian population. 
Little is known about the epidemiology of viral 
hepatitis in some Eastern European countries. Concern- 
ing hepatitis B, no immunization policy existed in Kosovo 
before the Balkan crisis. In fact, the immunization sched- 
ule adopted in Kosovo did not include vaccination against 
HBV In addition, it is likely that during the past decade 
the political and socioeconomic crisis in Kosovo, with 
the repression and marginalization of ethnic Albanians, 
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could have led to a worsening of the medical care sys- 
tem and of sanitary conditions. 
The goal of this study was to investigate a sample of 
Kosovar refugees to assess the prevalence of enteric and 
blood-borne transmission of viral hepatitis. 
MATERIALS AND METHODS 
Between March and April 1999 about 21,000 Kosovar 
refugees arrived in Puglia in an uninterrupted flow. After 
identification controls, the refugees were housed in eight 
refugee camps in Puglia. However, the number of refugees 
in the camps varied daily, because they quickly moved to 
other camps in different areas of Italy For the purpose of 
this study, a team of physicians and nurses went to the 
Puglian refugee camps. Every subject present in the 
camps on that day from 800 AM to 12:00 AM was asked 
to participate in a seroepidemiologic survey. After obtain- 
ing informed consent, a blood sample was taken on a vol- 
untary basis. The consent to take a blood sample from the 
children was obtained from their parents or legal 
guardians. More than 90% of refugees gave their consent, 
the remaining having fear of blood withdrawing. 
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Figure 1. Prevalence of anti-HAV antibodies in the Kosovar refugees 
by age group. 
used to compare proportions. If a P-value was below 0.05, 
the difference between proportions was considered to be 
statistically significant. 
RESULTS 
Personal data (age, gender, place of origin) were 
obtained from each of the 526 Kosovar refugees who 
were recruited for blood sampling. The blood samples 
were taken to the laboratory, centrifuged and stored at 
-20°C until testing. 
The sera collected were tested within 1 month for 
the following hepatitis markers: total anti-HAV (IgG and 
IgM), anti-HEV, hepatitis B surface antigen (HBsAg), anti- 
HBs, total anti-HBc (IgG and IgM), HBeAg, anti-HDV and 
anti-HCV Hepatitis A and hepatitis B markers were 
detected in serum samples by IMX-Microparticle Enzyme 
Immunoassay MEL4 (Abbott Diagnostics, Chicago, IL). 
Antibodies to hepatitis E virus were detected by an 
enzyme immunoassay (HEV IgG, Nuclear Laser Medicine, 
Milan, Italy). The repeatedly reactive samples were then 
confirmed by an immunoblot assay (RecomBlot HEV 
IgG/IgM, Mikrogen GmBH, Martinsried, Germany). Anti- 
bodies to hepatitis delta virus (anti-HDV IgG) were 
detected in HBsAg-positive subjects by a commercial 
enzyme immunoassay (HDV-Ab, Nuclear Laser Medicine). 
The presence of antibodies to hepatitis C virus (anti-HCV) 
was ascertained by a third generation enzyme-linked 
immunosorbent assay (ELISA) test (HCV 3.0 ELISA, Ortho 
Clinical Diagnostics, Milan, Italy). The repeatedly reactive 
serum samples were confirmed for the presence of anti- 
HCV antibodies using a recombinant immunoblot assay 
(Chiron RIBA HCV 3.0 X4, Ortho Diagnostic System). 
The interpretation of the results was carried out accord- 
ing to the manufacturer’s directions. 
Among the 526 Kosovar refugees, 255 (48.4%) were 
females and 271 (51.6%) were males. The refugees were 
from the areas of Kosovo most involved in the armed 
conflict: Pet (34%), Decane (15%), Djakovica (14%), 
Prizren (6%), Mitrovica (6%), Pristina (5%), Istok (4%), and 
Klina (3%). The remaining 13% of subjects were from 
other small villages in Kosovo. Children up to 10 years of 
age comprised 47.7% (251/526) of the study group; 119 
(22.6%) were 11 to 20 years of age; 85 (16.1%) were 21 
to 30 years of age, and 71 (13.5%) were older than 30 
years. The mean age of the recruits was 13 years (SD = 
11.35 y; range, 2-72 y). 
Figure 1 shows the prevalence of anti-HAV anti- 
bodies in the Kosovar refugees by age group. The over- 
all prevalence of total anti-HAV (IgG and IgM) was 81% 
(95% CI = 78.0-84.7). A relevant finding was the pres- 
ence of anti-HAV antibodies in 61% (95% CI = 54.9-66.9) 
of the children 2 to 10 years of age, whereas in the 
other age groups the prevalence was 100%. No signifi- 
cant difference in the prevalence rate for anti-HAV anti- 
bodies was found between males and females (71% vs. 
75%; P = 0.296). 
Analyses showed that 20 subjects (3.8%) (95% CI = 
2.1-5.4) yielded repeatedly reactive results by enzyme 
immunoassay for antibodies to hepatitis E virus (Table l), 
and 2.5% were confirmed to be seropositive by 
immunoblot assay Subjects seropositive for anti-HEV were 
from various areas of Kosovo and did not cluster. 
Data were processed using the software package Epi The prevalence of hepatitis B markers by age is 
Info (version 6.04~). Confidence intervals were calcu- reported in Table 2. Of the 2.9% (95% CI = 1.4-4.2) of 
lated by the quadratic method and chi-squared test was samples that yielded HBsAg-positive results (0.8%) (95% 
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Table 1. Prevalence of Antibodies to HEV in Kosovar Refugees by Age 
Reactive by f/A Confirmed by lmmunoblot Assay 
Number of Patients Number Positive 95% CI Number Positive 95% CI 
(n = 526) (n = 20) (3.8%) (2.2-5.4) (n = 73) (2.5%) (1.1-3.8) 
251 15 I:::; 3.0-8.1 9 (3.6) 1.3-5.9 
119 1 0.0-2.5 1 (‘3.8) 0.0-2.5 
85 2 (2.3) O.Ck5.6 2 (2.3) 0.0-5.6 
71 2 (2.8) 0.0-6.7 1 (1.4) 0.0-4.1 
EIA = enzyme immunoassay; Cl = confidence interval 
CI = O.O- 1.5) were also HBeAg-positive. Positivity for total 
anti-HBc (with or without anti-HBs) was detected in 
17.5% (95% CI = 14.2-20.7) of the refugees. When the 
results were stratified by age, the 21 to 30 age group was 
found to have the highest rate of HBsAg (7.1%; 95% CI = 
1.61-12.5) followed by the 11 to 20 (4.2%; 95% CI = 
O.6-7.8), the over 30 (4.2%; 95% CI = 0.0~8.9) and the 2 
to 10 (0.4%; 95% CI = 0.0-1.1) age groups. The propor- 
tion of refugees positive for HBV markers increased with 
age. None of the subjects was positive for anti-HBs alone. 
No difference between males and females emerged in 
the distribution of hepatitis B serologic markers (Table 3). 
In addition, none of the subjects yielded a positive result 
for antibodies to hepatitis D virus. A low prevalence of 
anti-HCV antibodies was found in the Kosovar refugees. 
In fact, among the 526 subjects tested, only 4 proved 
reactive by screening assay for anti-HCV; 3 adults (0.7%; 
95% CI = 0.0-1.2) were confirmed as seropositive by 
RIBA test (1 female; 2 males). No information was avail- 
able about the possible risk factors. 
DISCUSSION 
The present study reports the results of a survey to eval- 
uate the seroprevalence of viral hepatitis markers in a 
sample of refugees who arrived in Puglia region. Undoubt- 
edly the decision of enrolling subjects on a voluntary basis 
may have introduced a selection bias. The sample popu- 
lation studied may be considered biased with respect to 
Table 2. Serologic Markers of HBV Infection in Kosovar Refugees 
Number Positive (%) 
95% Confidence Interval 
Age Number of 
Group (y) Patients HBsAg 
2-10 251 1 (0.4) 
0.0-1.2 
11-20 119 5 (4.2) 
0.6-7.8 
21-30 85 6 (7.1) 
1.6-12.5 
>30 71 3 (4.2) 
0.0-8.9 
Total 526 15 (2.9) 
1.4-4.2 
anti-HBc anti-HBs 
15 (6.0) 
3.0-8.9 
24 (20.2) 
12.9-27.3 
22 (25.9) 
16.5-35.1 
31 (43.7) 
32.1-55.2 
92 (17.5) 
14.2-20.7 
12 (4.8) 
2.1-7.4 
16(13.4) 
7.3-19.5 
11 (12.9) 
5.8-20.0 
24 (33.8) 
22.8-44.8 
63 (12.0) 
9.2-14.7 
HBeAg 
0 (0.0) 
0.0-0.0 
2 (1.7) 
0.0-3.9 
1 (1.2) 
0.0-3.4 
1 (1.4) 
0.0-4.1 
4 (0.8) 
0.0-1.5 
the population in Kosovo and to the primarily young age 
of the subjects studied. In particular, the presence of a 
majority of younger people in the sample tested could 
have led to a possible underestimation in the population 
of the prevalence rate of some viral hepatitis markers. 
Nevertheless, some indications emerge from the present 
study. A high prevalence of total anti-HAV was found 
among refugees. Since none of the subjects present in the 
refugee camps showed clear symptoms of acute viral 
hepatitis at enrollment and there was no indication for 
anti-WV IgM detection, the high prevalence found strongly 
indicates previous infections. This finding suggests that 
Kosovo shows an epidemiologic pattern typical of hyper- 
endemic areas. These areas are characterized by poor 
hygienic, sanitary, and socioeconomic conditions and by 
the fact that HAV infection is largely acquired during child- 
hood.‘*-l6 In fact, the prevalence of total anti-HAV among 
the 2- to IO-year-old children reached 61%, confirming the 
high level of circulation of hepatitis A virus in the popu- 
lation since early life. The high prevalence rate for anti-HAV 
found in the Kosovar refugees was similar to that previ- 
ously reported for Albanian immigrants.11J7 It is conceiv- 
able that this high prevalence rate reflects the worsening 
of hygienic and sanitary conditions in Kosovo as a result 
of ethnic conflict during the past decade. In contrast, the 
overall prevalence of anti-HEV antibodies in this sample 
of refugees was low and comparable to that of other Euro 
pean countries. 18-22 An intriguing finding is the presence 
of seropositive subjects among the 2- to IO-year-olds. In 
non-endemic areas, HEV infection is rare among chil- 
dren.2S,24 Although no information on the risk factors of 
the refugees coming into Puglia is available, it is unlikely 
that the presence of antibodies in children 2 to 10 years 
of age could be ascribable to their having travelled to 
Table 3. HBV Markers by Gender in Kosovar Refugees 
HBsAg + anti-HBc + anti-HBs + HBeAg + 
Number (%) Number (%) Number (%) Number (%) 
Male 
(n = 271) 11 (4.0) 44(16.2) 30 (11.0) 
Female 
3 (1.1) 
(n =255) 5 (1.9) 45 (17.7) 36(14.1) 
P-value 
l(O.3) 
0.161 0.666 0.291 0.659* 
*Yates’ corrected cht-square. 
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disease-endemic zones. Therefore, a low-level circulation 
of hepatitis E virus in the Kosovo region could be sup- 
posed. More extensive studies, such as molecular studies 
on HEV would be needed to clarify this aspect. 
Concerning hepatitis B, results of this study are con- 
sistent with an intermediate level of endemicity of HBV 
infection in the Kosovar population. Since low prevalence 
of HBsAg carriers was found among the children sam- 
pled (0.4%) vertical transmission does not seem to be 
an important route of transmission. This hypothesis is 
also supported by the low prevalence of HBeAg in the 
elderly age categories and in particular among the females 
(0.3%). Therefore, the increasing prevalence of HBV mark- 
ers with age seems to indicate that hepatitis B infection 
in the Kosovar population is mainly acquired by sexual 
or parenteral exposure and by horizontal transmission. 
The prevalence of hepatitis B infection in the Koso- 
var population is signifcantly lower than that previously 
found in Albanian refugees coming into Puglia in 1997 
and clustered in the same age group~,~~-~~~*~ thus showing 
a profound difference in the risk factors between Koso- 
var and Albanian populations. In particular, Albanian chil- 
dren showed a higher prevalence rate of HBsAg carriers 
(16%) than Kosovar children. Moreover, HBV infection in 
the Kosovars seems to be at an endemic level compara- 
ble to that of other populations of the formerYugoslavia.” 
None of the Kosovar refugees was vaccinated against 
hepatitis B as suggested by the lack of antibodies to 
hepatitis B surface antigen alone. On the basis of these 
findings, the authors suggest that a universal immuniza- 
tion policy for hepatitis B may be advisable in this pop- 
ulation to control the spread of HBV infection. It has been 
reported that universal HBV vaccination is cost-effective 
even in countries with moderate to low HBV endemic- 
ity.27,2s In Italy, vaccination against hepatitis B has been 
compulsory since 1991 in newborns and children. There- 
fore, all Kosovar children staying in the refugee camps 
were immunized against hepatitis B, as recommended by 
the Italian Ministry of Health. 
On the basis of the results of the present survey, the 
authors suggest that an immunization strategy like that 
applied in Italy (vaccination to all newborns and children 
at the age of 12 years) may be adopted in Kosovo to con- 
trol HBV infection consistently with the available eco- 
nomic resources. In addition, also risk groups could be 
vaccinated against HBV Alternatively, only preadolescent 
children may be considered for immunization. The 
absence of antibodies to hepatitis delta virus confirms 
that HDV infection is not endemic in KOSOVO, although 
it has been reported to be endemic for the other areas 
of the former Yugoslavia. *9 Finally, antibodies to hepatitis 
C virus were detected in a low percentage of Kosovar 
refugees. This data is in agreement with the prevalence 
rates reported in the general population of other Euro- 
pean countries, ranging from 0.04% to 2%.“O However, 
the adoption of general preventive measures in the 
refugee population could help avoid the potential spread 
of HCV infection. 
Further studies on the Kosovar population may be 
necessary to confirm the present observations. Moreover, 
a monitoring of the Kosovar population could be help- 
ful during the reconstruction phase in that region, to eval- 
uate and plan adequate preventive measures. 
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